摘要
目的观察23G玻璃体切割手术下玻璃体切割术(PPV)联合白内障超声乳化术治疗白内障并玻璃体视网膜病变的临床疗效。方法使用随机数表法将2017年1月至2018年12月在我院就诊的90例白内障并玻璃体视网膜病变患者分为对照组(n=45)和观察组(n=45)。对照组接受常规PPV联合白内障超声乳化术治疗,观察组接受23G玻璃体切割手术下PPV联合白内障超声乳化术治疗。对比两组术前、术后1个月和术后6个月时的最佳矫正视力(LogMAR视力)和眼压水平;统计两组术后并发症发生率。结果观察组术后1个月、6个月时的最佳矫正视力(LogMAR视力)低于对照组(P<0.05);观察组术后1个月、6个月时的眼压水平低于对照组(P<0.05);观察组术后并发症发生率(6.67%)低于对照组(22.22%),差异有统计学意义(P<0.05)。结论 23G玻璃体切割手术联合白内障超声乳化术治疗白内障并玻璃体视网膜病变临床疗效好于常规手术,有利于最佳矫正视力及眼压水平恢复正常,且能减少并发症的发生率,具有临床推广价值。
Objective To observe the clinical efficacy of 23 G vitrectomy(PPV) combined with phacoemulsification of cataract in the treatment of cataract and vitreoretinopathy. Methods Using the random number table method, 90 patients with cataract and vitreoretinopathy who were treated in our hospital from January 2017 to December 2018 were divided into a control group(n=45) and an observation group(n=45). The control group received conventional PPV combined with cataract phacoemulsification, and the observation group received 23 G vitrectomy with PPV combined with cataract phacoemulsification. The best corrected visual acuity(LogMAR visual acuity) and intraocular pressure levels of the two groups before operation, 1 month after operation and 6 months after operation were compared;the incidence of postoperative complications in the two groups was calculated. Results The best corrected visual acuity(LogMAR visual acuity)of the observation group at 1 and 6 months after surgery was lower than that of the control group( <0.05);the intraocular pressure level of the observation group at 1 and 6 months after surgery was lower than The control group( <0.05);the postoperative complications rate of the observation group( 6.67%) was lower than that of the control group( 22.22%), and the difference was statistically significant( P<0.05). Conclusion 23 G vitrectomy combined with phacoemulsification for cataract is better than conventional surgery in the treatment of cataract and vitreoretinopathy. It is beneficial to the best corrected visual acuity and the return of intraocular pressure to normal, and can reduce the incidence of complications. It has clinical promotion value.
作者
郝中亮
HAO Zhong-liang(Department of Ophthalmology,the 16th People's Hospital of Zhengzhou,Dengfeng 452470,China)
出处
《实用防盲技术》
2021年第1期12-14,41,共4页
Journal of Practical Preventing Blind